Bleeding Disorders Bleeding disorders include a number of diseases that prevent proper blood clotting. Causes include abnormal platelet count, volume, morphology, function, and impaired coagulation. Proper clotting is critical for healing. If left untreated, uncontrolled bleeding due to a bleeding disorder can cause painful long-term effects like severe joint damage or viral infections. Obtaining a diagnosis allows for some bleeding disorders to be treated with the use of clotting factor concentrates or topical products applied in a hospital setting.
Bone Marrow Failure Bone marrow failure occurs when blood cells, including red cells, white cells and platelets are not produced in a sufficient quantity or the cells that are produced are defective or damaged. The overall decrease in mature blood cells is called cytopenia, and bone marrow failure can be associated with single (e.g. thrombocytopenia) or multiple lineage (e.g. thrombocytopenia, neutropenia, anemia) cytopenias. In addition to cytopenias, bone marrow failure is also associated with an increased risk for hematologic malignancies such as myelodysplastic syndrome and acute myeloid leukemia.
In 1964, President Lyndon B. Johnson proclaimed February American Heart Month as a way to increase awareness of heart diseases. Heart disease, also known as cardiovascular disease, is a broad term that describes a phenotypically and genetically heterogeneous group of diseases that impair the function or structure of the heart or both. Heart disease is the leading cause of death worldwide, accounting for 31% of all deaths (Cardiovascular Diseases). Environmental and behavioral factors are important aspects in the development of cardiovascular disease, but heredity plays a role as well.
DNA Banking is probably the most underappreciated and underutilized component of Genomic Medicine. In the United States alone, about 7,500 people die each day without leaving a DNA specimen. This is a terrible loss.
PreventionGenetics' Genetic Testing is Now Covered for Over 100 Million US Residents
PreventionGenetics is pleased to announce that as of November 15, 2019, we are in-network with seven new insurers. This announcement is a reflection of PreventionGenetics commitment to providing the highest quality genetic testing to all patients.